scholarly article | Q13442814 |
P356 | DOI | 10.1001/ARCHPSYC.1974.01760070040006 |
P698 | PubMed publication ID | 4587067 |
P2093 | author name string | Prange AJ Jr | |
Wilson IC | |||
Alltop LB | |||
Stikeleather RA | |||
Lynn CW | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | tryptophan | Q181003 |
P304 | page(s) | 56-62 | |
P577 | publication date | 1974-01-01 | |
P1433 | published in | JAMA Psychiatry | Q635830 |
P1476 | title | L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders | |
P478 | volume | 30 |
Q43254678 | 5-Hydroxytryptamine and dopamine pathways in mania: a pilot study of fenfluramine and pimozide |
Q34511931 | 5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology |
Q40897426 | A Controlled Trial of L-Tryptophan in Mania |
Q34461062 | A neurotransmitter basis for Eysenck's theory of personality |
Q51284043 | A study of the symptomatology and course of manic illness using a new scale |
Q48514520 | Antidepressant action of tryptophan |
Q37893018 | Antidepressants and brain neurochemistry |
Q68326300 | Association of affective disorder with migraine headaches and neurodermatitis |
Q36373052 | Bipolar disorder in childhood and adolescence |
Q50345609 | Blood platelets in psychopharmacological research |
Q68110014 | Brain kinetics of 11 C-labelled L-tryptophan and 5-hydroxy-L-tryptophan in the rhesus monkey. A study using positron emission tomography |
Q35170113 | Brain substrates of behavioral programs associated with self-regulation |
Q68476501 | Clonazepam Treatment of Atypical Bipolar Disorder |
Q35090072 | Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder |
Q44761415 | Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders |
Q34299446 | Depression as seen by the psychiatrist |
Q33773602 | Distinctions between bipolar and unipolar depression |
Q33963104 | Duloxetine pharmacology: profile of a dual monoamine modulator. |
Q44183794 | Effect of imipramine on 1-methyl-4-phenylpyridinium ion-induced hydroxyl radical generation in rat striatum |
Q39727429 | Effect of lithium and other drugs on the amphetamine chlordiazepoxide hyperactivity in mice |
Q39355386 | Effect of lithium on behavioral disinhibition induced by electrolytic lesion of the median raphe nucleus |
Q48741000 | Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors |
Q48660071 | Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission |
Q41449993 | Electroacupuncture: an alternative to antidepressants for treating affective diseases? |
Q40674621 | Endocrine Changes in Psychiatric Diseases |
Q40227041 | Enhancement of central norepinephrine and 5-hydroxytryptamine transmission by tricyclic antidepressants |
Q41545909 | Evaluation of role of the biogenic amines in affective illness: A clinical strategy |
Q33203078 | Imbalance of glial-neuronal interaction in synapses: a possible mechanism of the pathophysiology of bipolar disorder |
Q33938089 | Impact of substance abuse on the course and treatment of bipolar disorder |
Q67015139 | Increased platelet serotonin in bipolar depression and hypomania |
Q71621677 | Increased uptake of serotonin by blood platelets from patients with bipolar primary affective disorder-bipolar type |
Q49160410 | Inhibition by lithium of dopamine receptors in rat prolactin release |
Q73822633 | Inhibition of monkey brain semicarbazide-sensitive amine oxidase by various antidepressants |
Q41127949 | L-Tryptophan for Treatment of Depression? |
Q35223132 | L-Tryptophan in Neuropsychiatry Disorders: A Review |
Q39641473 | L-tryptophan: a rational anti-depressant and a natural hypnotic? |
Q35664109 | Lack of association between the norepinephrine transporter gene and major depression in a Han Chinese population. |
Q38138445 | Lithium and serotonin function: implications for the serotonin hypothesis of depression |
Q48713746 | Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers |
Q46850506 | Manic Disorder in Nigerians |
Q40112528 | Markers in psychoses: Studies from India |
Q46327960 | Methylene blue and its analogues as antidepressant compounds. |
Q88968268 | Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies |
Q35262086 | Neurochemical and Neuropharmacological Aspects of Depression |
Q42152479 | Neurochemical and psychoanalytical approaches to mania |
Q39501585 | Neurochemical mechanisms of mood stabilization. Focus on electroconvulsive therapy |
Q66932807 | Neuroendocrine responses to carbidopa in primary affective disorders |
Q34052805 | Neuropathology of bipolar disorder |
Q40111587 | Neurotransmitter Hypotheses of Depression: Research Update |
Q46652536 | Norepinephrine and serotonin imbalance in the locus coeruleus in bipolar disorder |
Q40020872 | Olfactory projection systems, drugs and behaviour: A review |
Q34376230 | Physiopathology of bipolar disorders: what have changed in the last 10 years? |
Q67437906 | Plasma Tryptophan Concentration in Depressive Illness and Mania |
Q41130821 | Platelet tritiated imipramine binding in patients suffering from mania |
Q44399663 | Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls |
Q36721893 | Psychedelic and entactogenic drugs in the treatment of depression |
Q48182013 | Psychometric evidence that mercury from silver dental fillings may be an etiological factor in depression, excessive anger, and anxiety |
Q40111112 | Psychotherapeutic Drugs and Biogenic Amines Current Concepts and Therapeutic Implications |
Q68142917 | Quantitative determination of pertussis toxin-sensitive G proteins using [32P]ADP-ribosylation in human platelet membranes: Negative correlation with ages |
Q34586026 | Rapid tryptophan depletion as a treatment for acute mania: a double-blind, pilot-controlled study |
Q33992239 | Recognizing and treating anxiety and depression in adolescents. Normal and abnormal responses |
Q44589253 | Reduced plasma levels of tyrosine, precursor of brain catecholamines, and of essential amino acids in patients with severe traumatic brain injury after rehabilitation |
Q48632816 | Regulation of central serotonin transporters by chronic lithium: an autoradiographic study |
Q31533726 | Relationship between depression and borderline personality disorder. |
Q39707932 | Review of the pharmacology of existing antidepressants |
Q38004458 | Role of serotonin in depression |
Q34604450 | Semicarbazide-sensitive amine oxidase (SSAO) in the brain |
Q41688718 | Sensory Deprivation and Homeostasis |
Q31125310 | Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies |
Q40181747 | Serotonergic function in the affective disorders: the effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol |
Q30482466 | Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression |
Q34185330 | Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies |
Q40856256 | Suicide: a four-pathway clinical-biochemical model |
Q40887716 | The Flinders sensitive line rats: a genetic animal model of depression |
Q37863666 | The brain serotonergic system in the affective disorders |
Q45762159 | The dental amalgam controversy: a review |
Q48411472 | The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors |
Q39222877 | The effect of neuroleptic derivatives of butyrophenone on the uptake of 5-HT by human blood platelets |
Q66923886 | The stimulation of rat brain monoamine oxidase by dietary lithium chloride |
Q43619110 | Three Cases of Unipolar Delusional Depression Responsive to L-Dopa |
Q67279232 | Transfer of sodium ions across the erythrocyte membrane in manic — Depressive illness: Treatment with lithium carbonate |
Q28318140 | Treatment of Cushing's disease with cyproheptadine |
Q33955775 | Tryptophan and 5-hydroxytryptophan for depression |
Q47357035 | Tryptophan depletion causes a rapid lowering of mood in normal males |
Q34552567 | Tryptophan-nicotinamide, imipramine and their combination in depression. A controlled study |
Q34661906 | l-Kynurenine Its synthesis and possible regulatory function in brain |
Search more.